For: | Liu H, Yuan SJ, Chen YT, Xie YB, Cui L, Yang WZ, Yang DX, Tian YT. Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma. World J Gastroenterol 2013; 19(31): 5138-5143 [PMID: 23964149 DOI: 10.3748/wjg.v19.i31.5138] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i31/5138.htm |
Number | Citing Articles |
1 |
Evelyne Tassone, Michela Muscolini, Nadine van Montfoort, John Hiscott. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?. Cytokine & Growth Factor Reviews 2020; 56: 141 doi: 10.1016/j.cytogfr.2020.07.015
|
2 |
Lihong Wang, Louisa S Chard Dunmall, Zhenguo Cheng, Yaohe Wang. Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment. Journal for ImmunoTherapy of Cancer 2022; 10(5): e004167 doi: 10.1136/jitc-2021-004167
|
3 |
Ding Wei, Qian Li, Xi-Long Wang, Yuan Wang, Jing Xu, Fei Feng, Gang Nan, Bin Wang, Can Li, Ting Guo, Zhi-Nan Chen, Huijie Bian. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0271-1
|
4 |
Nicholas Denton, Chun-Yu Chen, Thomas Scott, Timothy Cripe. Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?. Biomedicines 2016; 4(3): 13 doi: 10.3390/biomedicines4030013
|
5 |
Dong Wang, Xian-Wang Wang, Xiao-Chun Peng, Ying Xiang, Shi-Bao Song, Ying-Ying Wang, Lin Chen, Victoria W. Xin, Yan-Ning Lyu, Jiafu Ji, Zhao-Wu Ma, Cheng-Bin Li, Hong-Wu Xin. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research. Cancer Gene Therapy 2018; 25(5-6): 93 doi: 10.1038/s41417-018-0016-3
|
6 |
Ludi Yang, Xiang Gu, Jie Yu, Shengfang Ge, Xianqun Fan. Oncolytic Virotherapy: From Bench to Bedside. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.790150
|
7 |
Xianwang Wang, Yihua Shen, Xingxia Wan, Xiaoqing Hu, Wen-Qi Cai, Zijun Wu, Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin, Hong-Wu Xin. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04360-8
|
8 |
Kaitlyn J. Kelly, Joyce Wong, Mithat Gönen, Peter Allen, Murray Brennan, Daniel Coit, Yuman Fong. Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer. EBioMedicine 2016; 7: 94 doi: 10.1016/j.ebiom.2016.03.043
|
9 |
Nicholas L. Denton, Chun-Yu Chen, Brian Hutzen, Mark A. Currier, Thomas Scott, Brooke Nartker, Jennifer L. Leddon, Pin-Yi Wang, Rachelle Srinivas, Kevin A. Cassady, William F. Goins, Timothy P. Cripe. Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment. Molecular Therapy - Oncolytics 2018; 11: 62 doi: 10.1016/j.omto.2018.10.001
|
10 |
Molly C. Holbrook, Dakota W. Goad, Valery Z. Grdzelishvili. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers 2021; 13(5): 1171 doi: 10.3390/cancers13051171
|
11 |
Simona Ruxandra Volovat, Dragos Viorel Scripcariu, Ingrid Andrada Vasilache, Cati Raluca Stolniceanu, Constantin Volovat, Iolanda Georgiana Augustin, Cristian Constantin Volovat, Madalina-Raluca Ostafe, Slevoacă-Grigore Andreea-Voichița, Toni Bejusca-Vieriu, Cristian Virgil Lungulescu, Daniel Sur, Diana Boboc. Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy. International Journal of Molecular Sciences 2024; 25(2): 1180 doi: 10.3390/ijms25021180
|
12 |
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 2016; 5(2): e1117740 doi: 10.1080/2162402X.2015.1117740
|
13 |
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean-Marc Limacher, Xavier Preville, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial Watch:. OncoImmunology 2014; 3(6): e28694 doi: 10.4161/onci.28694
|
14 |
Giulia Mesiano, Roberta Zini, Giulia Montagner, Nicoletta Bianchi, Rossella Manfredini, Antonella Chillemi, Massimo Aglietta, Giovanni Grignani, Ilaria Lampronti, Erika Fiorino, Fabio Malavasi, Dario Sangiolo, Roberto Gambari, Davide Ferrari. Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-lnduced Killer Cells. Molecular Medicine 2017; 23(1): 235 doi: 10.2119/molmed.2017.00084
|
15 |
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, Sumair Naseem Qureshi, Hussnain Ahmed Janjua. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.875188
|
16 |
Altaf Mohammed, Naveena Janakiram, Shubham Pant, Chinthalapally Rao. Molecular Targeted Intervention for Pancreatic Cancer. Cancers 2015; 7(3): 1499 doi: 10.3390/cancers7030850
|
17 |
R. Eftimiea, G. Eftimie. Tumour-Associated Macrophages and Oncolytic Virotherapies: A Mathematical Investigation into a Complex Dynamics. Letters in Biomathematics 2018; 5(2) doi: 10.30707/LiB5.2Eftimiea
|